Wolverine Trading, LLC Incyte Corp Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $687,960 - $823,320	12,000 Added 187.5%	18,400 $1.22 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $97,242 - $121,125	-1,900 Reduced 22.89%	6,400 $387,000
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $39,585 - $46,613	-700 Reduced 7.78%	8,300 $472,000
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $469,439 - $577,710	9,000 New	9,000 $565,000
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $349,336 - $437,372	5,200 New	5,200 $418,000
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $1.63 Million - $2.05 Million	-24,700 Reduced 85.76%	4,100 $311,000
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $779,036 - $940,577	11,800 Added 69.41%	28,800 $2.29 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $120,346 - $140,809	1,900 Added 12.58%	17,000 $1.26 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $82,404 - $100,824	1,200 Added 8.63%	15,100 $1.04 Million
Q2 2021 Aug 06, 2021	SELL	$79.87 - $87.53 $55,909 - $61,271	-700 Reduced 4.79%	13,900 $1.18 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $2.74 Million - $3.62 Million	-36,000 Reduced 71.15%	14,600 $1.17 Million
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $912,362 - $1.1 Million	-11,300 Reduced 18.26%	50,600 $4.4 Million
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $85,070 - $109,690	-1,000 Reduced 1.59%	61,900 $5.41 Million
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $749,218 - $1.1 Million	-10,100 Reduced 13.84%	62,900 $6.45 Million
Q1 2020 May 11, 2020	SELL	$63.18 - $85.97 $284,310 - $386,865	-4,500 Reduced 5.81%	73,000 $5.27 Million
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $204,512 - $268,016	2,800 Added 3.75%	77,500 $6.82 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $728,199 - $865,200	-10,000 Reduced 11.81%	74,700 $5.44 Million
Q2 2019 Aug 20, 2019	BUY	$73.52 - $88.7 $1.57 Million - $1.89 Million	21,300 Added 33.6%	84,700 $7.2 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $1.33 Million - $1.85 Million	-21,000 Reduced 24.88%	63,400 $5.45 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $1.25 Million - $1.49 Million	21,300 Added 33.76%	84,400 $5.26 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $185,250 - $222,690	-3,000 Reduced 4.54%	63,100 $4.36 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $921,966 - $1.12 Million	11,100 Added 20.18%	66,100 $5.51 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $467,800 - $583,000	5,000 Added 10.0%	55,000 $5.21 Million
Q3 2017 Nov 15, 2017	BUY	$109.15 - $138.27 $5.46 Million - $6.91 Million	50,000	50,000 $5.84 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account